K-Dur Applies To Authorized Generic Deals, FTC Insists

Law360, New York (October 9, 2012, 6:37 PM EDT) -- The Federal Trade Commission on Friday once again urged a federal court to apply the Third Circuit's recent K-Dur ruling on pay-for-delay deals to a case targeting an authorized generic settlement, this time in a putative class action against GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd.

The antitrust watchdog lodged a proposed amicus brief with the New Jersey federal court overseeing a case that accuses GSK and Teva of conspiring to keep a generic version of epilepsy drug Lamictal off the market in order to maximize...
To view the full article, register now.